A detailed history of Advisor Net Financial, Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Advisor Net Financial, Inc holds 1,297 shares of CRSP stock, worth $62,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,297
Previous 1,100 17.91%
Holding current value
$62,100
Previous $59,000 1.69%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$44.62 - $62.75 $8,790 - $12,361
197 Added 17.91%
1,297 $60,000
Q2 2024

Jul 16, 2024

SELL
$51.17 - $68.18 $3,070 - $4,090
-60 Reduced 5.17%
1,100 $59,000
Q1 2024

Apr 12, 2024

BUY
$60.67 - $89.12 $8,190 - $12,031
135 Added 13.17%
1,160 $79,000
Q3 2023

Oct 12, 2023

SELL
$45.39 - $59.0 $11,347 - $14,750
-250 Reduced 19.61%
1,025 $46,000
Q2 2023

Jul 14, 2023

BUY
$43.47 - $67.77 $32,602 - $50,827
750 Added 142.86%
1,275 $71,000
Q4 2022

Jan 13, 2023

SELL
$39.19 - $65.67 $78 - $131
-2 Reduced 0.38%
525 $0
Q2 2022

Jul 07, 2022

SELL
$43.23 - $73.83 $1,426 - $2,436
-33 Reduced 5.89%
527 $32,000
Q1 2022

Apr 14, 2022

BUY
$53.19 - $79.24 $1,329 - $1,980
25 Added 4.67%
560 $35,000
Q4 2021

Jan 19, 2022

SELL
$70.09 - $111.29 $34,344 - $54,532
-490 Reduced 47.8%
535 $41,000
Q3 2021

Oct 15, 2021

BUY
$110.2 - $156.64 $1,432 - $2,036
13 Added 1.28%
1,025 $115,000
Q1 2021

Apr 14, 2021

BUY
$110.72 - $210.04 $106,291 - $201,638
960 Added 1846.15%
1,012 $123,000
Q4 2020

Feb 04, 2021

BUY
$79.67 - $173.23 $3,983 - $8,661
50 Added 2500.0%
52 $8,000
Q2 2020

Aug 26, 2020

BUY
$38.5 - $76.05 $77 - $152
2 New
2 $0

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.